FIELD: chemistry; pharmaceutical industry.
SUBSTANCE: invention relates to a product based on selenium dioxide and sulfated arabinogalactan, which is characterized by having antitumor activity and is a dry water-soluble powder with a selenium content of 5.00–17.40% and a composite size of 5–50 nm, while selenium-containing structures are mechanochemically introduced into the matrix of sulfated arabinogalactan.
EFFECT: invention provides a selenium-containing nanocomposite of sulfated arabinogalactan with antitumor activity, which is not toxic to normal mammalian cells.
1 cl, 4 dwg, 1 tbl, 8 ex
| Title | Year | Author | Number |
|---|---|---|---|
| AGENT WITH ANTITUMOR ACTIVITY BASED ON ARABINOGALACTAN NANOCOMPOSITES WITH SELENIUM AND METHODS FOR PREPARIATION OF SUCH NANOBIOCOMPOSITES | 2015 |
|
RU2614363C2 |
| AGENT HAVING ANTI-TUMOUR ACTIVITY | 2023 |
|
RU2819039C1 |
| SILVER NANOCOMPOSITE BASED ON ARABINOGALACTAN CONJUGATE AND FLAVONOIDS WITH ANTIMICROBIAL AND ANTITUMOR ACTION AND PREPARATION METHOD THEREOF | 2015 |
|
RU2611999C2 |
| METHOD FOR OBTAINING IODINE-CONTAINING ARABINOGALACTAN COMPOSITES WITH ANTIMICROBIAL AND ANTIFUNGAL PROPERTIES | 2022 |
|
RU2795219C1 |
| BETULIN DIACETATE-BASED COMPOSITION | 2013 |
|
RU2517157C1 |
| DIPROPIONATE BETULIN COMPOSITION | 2013 |
|
RU2541153C1 |
| METHOD OF PRODUCING SELENIUM NANOPARTICLES IN COLLOIDAL FORM DURING PRODUCTION OF BIOLOGICALLY ACTIVE ADDITIVES | 2018 |
|
RU2717997C2 |
| METHOD OF DESTROYING TUMOR ASCITES CELLS USING MAGNETIC NANODISCS AND APTAMERS IN CONDITIONS OF ALTERNATING ELECTROMAGNETIC FIELD | 2023 |
|
RU2814394C1 |
| DERIVATIVE OF THE CLASS OF N-GLYCOSIDES INDOLO[2,3-A]PYRROLO[3,4-C]CARBAZOLE-5,7-DIONE - N-{12-(β-D-XYLOPYRANOSYL)-5,7-DIOXO-INDOLO[2,3-A]PYRROLO[3,4-C]CARBAZOL-6-YL} PYRIDINE-2-CARBOXAMIDE, WHICH HAS CYTOTOXIC AND ANTITUMOR ACTIVITY | 2017 |
|
RU2667906C1 |
| FLUORESCENT SENSOR FOR DETECTING LYSOSOMES IN VITRO | 2019 |
|
RU2717308C1 |
